logo
Trail cams catch chimpanzees sharing fruit — with alcohol. See ‘boozy' encounter

Trail cams catch chimpanzees sharing fruit — with alcohol. See ‘boozy' encounter

Miami Herald22-04-2025
In what is believed to be a world first, trail cameras in western Africa have filmed and photographed wild chimpanzees sharing fruit containing alcohol.
But, was it intentional?
The first-of-its-kind discovery has raised more questions than answers for researchers working in Guinea-Bissau's Cantanhez National Park, according to a study published April 21 in the peer-reviewed journal Current Biology.
The team set up motion-activated trail cameras throughout the park to better study the feeding and sharing behaviors of wild chimpanzees. The chimpanzees in this park are 'unhabituated' to researchers, according to the study.
'Chimpanzees were seen to regularly select and feed on T. africana (African breadfruit) when available. Sharing was observed on 10 separate occasions between 17 individuals across all age- and sex-classes,' researchers said. 'At the time of sharing, 90% of the shared fruits contained ethanol.'
African breadfruit contains ethanol when fermented, so the researchers tested the fruit to see just how 'boozy' it really was, according to an April 21 news release from the University of Exeter.
When they calculated the fruit's alcohol by volume — the same measure used for alcoholic drinks — they found values up to 0.61% ABV, a 'relatively low' amount, according to the release.
A single serving of beer is 12 ounces, for example, and has an ABV of 5%, while a typical 5 ounces of wine has a 12% ABV. The ABV in the booziest African breadfruit was similar to that in kombucha, a fermented tea drink, which can have about 0.5% ABV.
'But the researchers say it may be the 'tip of the iceberg', as 60-80% of chimps' diet is fruit — so low levels of alcohol in various foods could add up to significant consumption,' according to the release.
The chimpanzees are, however, unlikely to get 'drunk' as it would be a significant hindrance to their survival chances, researchers said.
'Chimps don't share food all the time, so this behavior with fermented fruit might be important,' researcher Kimberley Hockings, from the University of Exeter, said in the release. 'We need to find out more about whether they deliberately seek out ethanolic fruits and how they metabolize it, but this behavior could be the early evolutionary stages of 'feasting.' If so, it suggests the human tradition of feasting may have its origins deep in our evolutionary history.'
The tradition of drinking and sharing alcohol runs deep in human history, with beer possibly being made as far back as 13,000 years ago, according to History.com.
'For humans, we know that drinking alcohol leads to a release of dopamine and endorphins, and resulting feelings of happiness and relaxation,' lead author Anna Bowland, from the Centre for Ecology and Conservation with the University of Exeter, said in the release. 'We also know that sharing alcohol — including through traditions such as feasting — helps to form and strengthen social bonds. So – now we know that wild chimpanzees are eating and sharing ethanolic fruits — the question is: could they be getting similar benefits?'
Cantanhez National Park is in southern Guinea-Bissau, a country on the west-central coast of Africa.
The research team includes Bowland, Hockings, Elena Bersacola, Marina Ramon, Joana Bessa, Amanda Melin, Matthew Carrigan and Xavier Harrison.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Beetroot Juice's Blood Pressure Secret: The Nitrate Effect
Beetroot Juice's Blood Pressure Secret: The Nitrate Effect

Medscape

time8 hours ago

  • Medscape

Beetroot Juice's Blood Pressure Secret: The Nitrate Effect

A study from the University of Exeter, Exeter, England, found that regular consumption of beetroot juice may help lower blood pressure in adults over 60 years of age. Beetroot is naturally rich in micronutrients and minerals, and its nitrate content plays a central role in this effect. Evidence has shown that poor oral health and microbial imbalances can reduce the body's ability to convert dietary nitrate into nitric oxide, a compound essential for blood pressure regulation. These findings highlight the potential cardiovascular benefits of nitrate-rich foods, such as beetroot juice. Study Details The placebo-controlled, double-blind crossover trial involved 39 participants under 30 and 36 healthy elderly individuals 60-70 years of age. Individuals from both the group consumed the nitrate-rich beetroot juice (750 mg of nitrate) daily for 2 weeks and then, after a 2-week washout period, a placebo version of the juice without nitrate. Researchers analyzed the oral microbiomes of the participants through gene sequencing before and after a 2-week regimen of twice-daily antiseptic mouthwash use. Key Findings At baseline, the microbiome did not differ between younger and older adults. After consuming nitrate-rich juice, individuals from both groups showed changes, but the effects differed. In older adults, harmful bacteria such as Prevotella decreased, whereas beneficial bacteria such as Neisseria increased. This shift was associated with higher nitrite levels. Older participants had a slightly higher average blood pressure (126/80 mm Hg). With nitrate-rich juice, their blood pressure dropped by approximately 7 mm Hg. No effect was seen with placebo juice or in younger adults who already had normal blood pressure. These findings suggest that nitrate lowers blood pressure by reducing harmful oral bacteria and improving the conversion of nitrate to nitric oxide. This mechanism may be particularly important in older adults as natural nitric oxide production declines with age. Foods rich in nitrate, such as spinach, arugula, fennel, celery, and kale, may provide similar benefits. Larger studies are needed to confirm these effects in older adults. This story was translated from Coliquio.

Study: Elephants Only Other Species Capable Of Leveraging Synergies In Brand Portfolio
Study: Elephants Only Other Species Capable Of Leveraging Synergies In Brand Portfolio

The Onion

timea day ago

  • The Onion

Study: Elephants Only Other Species Capable Of Leveraging Synergies In Brand Portfolio

ITHACA, NY—In a groundbreaking study published in the journal Animal Behaviour , researchers at Cornell University revealed Monday that elephants are the only known nonhuman species capable of leveraging synergies across a diversified brand portfolio. 'Conventional wisdom has long held that leveraging omnibrand fluidity to unlock cross-platform capital efficiencies was a behavior unique to humans, but in the wild we have observed multiple African elephant groups with a highly evolved capacity for optimizing cross-vertical integration through holistic brand harmonization at scale,' said Professor Mia Sherin, who noted that elephant corporate structures are matriarchal, and females consistently serve as project managers across multiplatform activations, seamlessly executing cross-functional touchpoints and asynchronous ideation cycles. 'This marks one of the most advanced examples of nonhuman tool use ever recorded. We've observed elephants utilizing Microsoft Excel for longitudinal KPI tracking, assembling low-fidelity mood boards to map brand essence, and creating rudimentary LinkedIn profiles to strengthen B2B positioning. In one case, a juvenile even led a rapid-fire ideation sprint that resulted in a fully actualized multichannel activation plan. This study brings us one step closer to the dream of true interspecies communication, should we ever manage to put some time down on their calendars to connect over a coffee.' At press time, Sherin's team traveled back to Tanzania to study how different elephant groups mourn, as they are thought to be the only other animals known to grieve their profit losses.

Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa
Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa

Business Wire

timea day ago

  • Business Wire

Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)-- Butterfly Network, Inc. ('Butterfly', 'the Company') (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced its role in the international research study CAD LUS4TB that will evaluate the impact of AI-assisted point-of-care ultrasound (POCUS) on tuberculosis (TB) triage in under-resourced settings. For patients in regions such as Sub-Saharan Africa (SSA) with no access to ultrasound in primary care, there is a critical need for accessible diagnostic tools. WHO data suggests that 2.5 million people fell ill with TB in Africa in 2022, accounting for a quarter of new TB cases worldwide, and over 33% of TB deaths occurred in the African region. Butterfly is part of the CAD LUS4TB consortium alongside 10 research institutions in Africa and Europe. The consortium is trialing a new AI algorithm, using Butterfly's software development platform. The program automates image classification for TB from images obtained using Butterfly's portable ultrasound devices. AI-aided POCUS will be used to help frontline healthcare workers quickly and more accurately detect TB at point of care in an initial trial in the SSA region. The European Union's Global Health EDCTP3 Joint Undertakings has provided €10 million in funding for this work. The trial initiates in September and will involve 3,000 adult patients across SSA. Patients will be treated by non-radiologist healthcare workers supported by AI-led POCUS to identify likely TB indicators. This approach empowers healthcare workers to assess patients for TB without needing extensive ultrasound training or access to lab testing. 'Butterfly is proud to continue improving global health equity through our role in this project. Patients in lower-resource settings need easier access to diagnostic imaging to detect and treat deadly diseases such as TB before it claims more lives,' said Dr. Sachita Shah, VP of Global Health, Butterfly Network. 'We believe that this study has the capacity to demonstrate that faster, safer, more accessible triage with AI-enabled POCUS can drastically reduce morbidity and mortality from TB and other lung diseases in low- and middle-income countries.' The CAD LUS4TB initiative also seeks to generate an evidence-driven policy that supports AI-aided lung ultrasound in TB management, with the long-term goal of the technology's incorporation into national healthcare policies and systems. Powered by the company's Ultrasound-on-Chip™ technology, Butterfly delivers sharp image quality and powerful AI capabilities in a single handheld probe. Butterfly's portable hardware, coupled with the company's partner platform for software development, uniquely positions Butterfly POCUS as a suitable vehicle for deploying new, innovative AI algorithms to diagnose leading causes of global mortality, including TB. The study is the latest innovation in Butterfly's ongoing commitment to improving access to ultrasound for healthcare professionals and patients globally, particularly in underserved areas. Butterfly previously supported the TrUST study, an international prospective trial which developed AI algorithms for diagnosis of TB using Butterfly. Butterfly's Global Health Program works with hundreds of non-profit and humanitarian organizations in over 115 countries to provide sustainable and equitable digital health solutions to the world's most vulnerable populations. About Butterfly Network Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world's first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore's Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly's innovations have also been recognized by Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about Butterfly's Global Health Program, please visit:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store